BioSenic S.A. (BIOS.BR)

EUR 0.0

(7.69%)

Total Assets Summary of BioSenic S.A.

  • BioSenic S.A.'s latest annual total assets in 2023 was 9.55 Million EUR , down -67.4% from previous year.
  • BioSenic S.A.'s latest quarterly total assets in 2024 Q1 was 9.39 Million EUR , down -1.71% from previous quarter.
  • BioSenic S.A. reported annual total assets of 29.32 Million EUR in 2022, up 48.31% from previous year.
  • BioSenic S.A. reported annual total assets of 19.77 Million EUR in 2021, down -20.39% from previous year.
  • BioSenic S.A. reported quarterly total assets of 9.39 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • BioSenic S.A. reported quarterly total assets of 9.55 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of BioSenic S.A. (2023 - 2011)

Historical Annual Total Assets of BioSenic S.A. (2023 - 2011)

Year Total Assets Total Assets Growth
2023 9.55 Million EUR -67.4%
2022 29.32 Million EUR 48.31%
2021 19.77 Million EUR -20.39%
2020 24.83 Million EUR 10.91%
2019 22.39 Million EUR -13.05%
2018 25.75 Million EUR 2.3%
2017 25.17 Million EUR -34.76%
2016 38.58 Million EUR -23.42%
2015 50.38 Million EUR 108.18%
2014 24.2 Million EUR 88.92%
2013 12.81 Million EUR -11.15%
2012 14.41 Million EUR -4.22%
2011 15.05 Million EUR 0.0%

Peer Total Assets Comparison of BioSenic S.A.

Name Total Assets Total Assets Difference
Nicox S.A. 52.98 Million EUR 81.957%
European Medical Solutions 43.75 Million EUR 78.155%
FERMENTALG 50.24 Million EUR 80.975%
argenx SE 4.11 Billion EUR 99.768%
Celyad Oncology SA 16.28 Million EUR 41.291%
Hyloris Pharmaceuticals SA 47.68 Million EUR 79.952%
Onward Medical N.V. 43.62 Million EUR 78.09%
Oxurion NV 6.55 Million EUR -45.939%
PHAXIAM Therapeutics S.A. 51.3 Million EUR 81.369%
Financière de Tubize SA 1.92 Billion EUR 99.502%
UCB SA 15.53 Billion EUR 99.938%